SCHEMBL3233608

SCHEMBL3233608

N#Cc1ccc([C@H]2CC[C@H](NC3CC3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.47
GRIA1 P42261 1/20 0.46
GRIA2 P42262 1/20 0.46
GRIA3 P42263 1/20 0.46
MAOB P27338 2/20 0.44
KDM1A O60341 1/20 0.44
IRAK4 Q9NWZ3 1/20 0.42
EGLN2 Q96KS0 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HSD11B1 P28845 1/20 0.38
EPHX1 P07099 1/20 0.37
MAOA P21397 1/20 0.37
SLC6A4 P31645 1/20 0.37
CYP19A1 P11511 1/20 0.36
P2RY14 Q15391 1/20 0.36
GRIA4 P48058 1/20 0.36
USP30 Q70CQ3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3233615 1.00 GRIN2B (0.47) GRIN2BGRIA1GRIA2GRIA3MAOB
SCHEMBL5958188 0.88 GRIA1 (0.49) GRIA1GRIA2GRIA3MAOBEGLN2
SCHEMBL13470585 0.85 GRIA1 (0.47) GRIA1GRIA2GRIA3MAOBKDM1A
SCHEMBL13621591 0.82 GRIA1 (0.46) GRIA1GRIA2GRIA3MAOBEGLN2
SCHEMBL13674322 0.81 SLC6A4 (0.50) GRIA1GRIA2GRIA3EGLN2KCNH2
SCHEMBL21574447 0.80 GRIA1 (0.44) GRIA1GRIA2GRIA3MAOBEGLN2
SCHEMBL11568772 0.80 TSHR (0.52) GRIN2BGRIA1GRIA2GRIA3MAOB
SCHEMBL3706669 0.79 KCNH2 (0.46) GRIA1GRIA2GRIA3MAOBKCNH2
SCHEMBL250894 0.79 MAOA (0.50) GRIA1GRIA2GRIA3MAOBKCNH2
SCHEMBL23197880 0.78 GRIA1 (0.43) GRIA1GRIA2GRIA3MAOBEGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637576-B2 Benzamide derivatives and uses related thereto AMGEN INC. (US) 2014-01-28 US disclosed
US-8637576-B2 Benzamide derivatives and uses related thereto AMGEN INC. (US) 2014-01-28 US disclosed
US-8637576-B2 Benzamide derivatives and uses related thereto AMGEN INC. (US) 2014-01-28 US disclosed
EP-1904435-B1 BENZAMIDE DERIVATIVES AND USES RELATED THERETO AMGEN INC (US) 2013-01-02 EP disclosed
EP-1904435-B1 BENZAMIDE DERIVATIVES AND USES RELATED THERETO AMGEN INC (US) 2013-01-02 EP disclosed
US-20100069447-A1 BENZAMIDE DERIVATIVES AND USES RELATED THERETO AMGEN INC. 2010-03-18 US disclosed
US-7605289-B2 Benzamide derivatives and uses related thereto AMGEN, INC. (US) 2009-10-20 US disclosed
US-7605289-B2 Benzamide derivatives and uses related thereto AMGEN, INC. (US) 2009-10-20 US disclosed
US-20060293392-A1 Benzamide derivatives and uses related thereto AMGEN INC. 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293392-A1 Benzamide derivatives and uses related thereto GPR119, GLP1R, UGT2B7 GRIN2B 2921/4885GRIA1 2536/4885GRIA2 2656/4885
US-20100069447-A1 BENZAMIDE DERIVATIVES AND USES RELATED THERETO GPR119, GLP1R, UGT2B7 GRIN2B 2921/4885GRIA1 2536/4885GRIA2 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.